Comprehensive analysis of gp120 glycosylation to explore differences between transmitter/founder and chronic HIV-1 isolates. [PDF]
Temesy S +11 more
europepmc +1 more source
Crystal structure of HERV-K envelope glycoprotein surface subunit. [PDF]
Nikolopoulos N, Modis Y.
europepmc +1 more source
Quercetin ameliorates HIV-1 gp120 protein-induced intestinal barrier dysfunction by inhibiting the activation of the ERK1/2 signaling pathway in a Caco-2 cell model. [PDF]
Zhu L +6 more
europepmc +1 more source
Protein-dependent CD4<sup>+</sup> T cell specialization and CD8<sup>+</sup> T cell-driven IL-2 production in HIV. [PDF]
Pušnik J +5 more
europepmc +1 more source
Virus particle-based antibody-dependent cellular phagocytosis assay for HIV. [PDF]
Upadhyay C, Rao PG.
europepmc +1 more source
AS01<sub>B</sub>-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702. [PDF]
Menezes F +15 more
europepmc +1 more source
Retraction Note: Neuroprotective effects of the Immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity. [PDF]
Fields JA +9 more
europepmc +1 more source
Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV. [PDF]
Benlarbi M +11 more
europepmc +1 more source
LncRNA SNHG1 Knockdown Ameliorates HIV-1 gp120V3 Loop-Induced Microglial Neuroinflammation by Regulating the Autophagy Process. [PDF]
Yan X +12 more
europepmc +1 more source
Neuroinflammation and NeuroHIV: understanding the role of HIV-1 related factors in microglial activation. [PDF]
Zhao J, Bu F, Wu H, He J, Liu J.
europepmc +1 more source

